Truist lowered the firm’s price target on Treace Medical (TMCI) to $9.50 from $10 and keeps a Hold rating on the shares after its recent ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest ...

The list of potential procedures includes a meniscus replacement, low-dose radiation therapy or something known as osteotomy that would require doctors to "break a bone in the hip to realign the ...